Cargando…

Interleukin‐1 blockade in heart failure: an on‐treatment and off‐treatment cardiorespiratory fitness analysis

AIMS: Interleukin‐1 (IL‐1) blockade may improve exercise capacity in patients with heart failure (HF) patients. The extent of the improvement and its persistence beyond discontinuation of IL‐1 blockade is unknown. METHODS AND RESULTS: The primary objective was to determine changes in cardiorespirato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moroni, Francesco, Golino, Michele, Carbone, Salvatore, Trankle, Cory, Del Buono, Marco Giuseppe, Talasaz, Azita, Arena, Ross, Canada, Justin M., Biondi‐Zoccai, Giuseppe, Van Tassel, Benjamin, Abbate, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567671/ https://www.ncbi.nlm.nih.gov/pubmed/37403287 http://dx.doi.org/10.1002/ehf2.14460

Ejemplares similares

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022)

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study
por: Van Tassell, Benjamin, et al.
Publicado: (2022)

Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra
por: Golino, Michele, et al.
Publicado: (2023)

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Abbate, Antonio, et al.
Publicado: (2020)

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
por: van Wezenbeek, Jessie, et al.
Publicado: (2018)

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction
por: Carbone, Salvatore, et al.
Publicado: (2017)

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
por: Trankle, Cory, et al.
Publicado: (2017)

Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
por: Buckley, Leo F., et al.
Publicado: (2018)

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study
por: Carbone, Salvatore, et al.
Publicado: (2019)

Lifestyle Interventions with a Focus on Nutritional Strategies to Increase Cardiorespiratory Fitness in Chronic Obstructive Pulmonary Disease, Heart Failure, Obesity, Sarcopenia, and Frailty
por: Billingsley, Hayley E., et al.
Publicado: (2019)

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
por: Carbone, Salvatore, et al.
Publicado: (2020)

2363: Ventriculo-arterial coupling and left ventricular mechanical work in systolic and diastolic heart failure
por: Buckley, Leo, et al.
Publicado: (2018)

Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy
por: Canada, Justin M., et al.
Publicado: (2020)

3415 Percent Predicted Peak Exercise Oxygen Pulse Is a Marker of Cardiac Reserve Following Thoracic Radiotherapy
por: Canada, Justin McNair, et al.
Publicado: (2019)

Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation
por: Trankle, Cory, et al.
Publicado: (2016)

Cardiologic side effects of psychotropic drugs
por: Marano, Giuseppe, et al.
Publicado: (2011)

Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021)

Rethinking interleukin-6 blockade for treatment of COVID-19
por: Scherger, S., et al.
Publicado: (2020)

Interleukin‐1 blockade treatment decreasing cardiovascular risk
por: Zheng, Zi‐Heng, et al.
Publicado: (2019)

Network Meta-analysis to Synthesize Evidence for Decision Making in Cardiovascular Research
por: Roever, Leonardo, et al.
Publicado: (2016)

Late Pseudoaneurysm after Manta Use for Transfemoral Aortic Valve Implantation: A Call for Caution?
por: Roever, Leonardo, et al.
Publicado: (2018)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer
por: Toldo, Stefano, et al.
Publicado: (2017)

Metabolic modulation predicts heart failure tests performance
por: Contaifer, Daniel, et al.
Publicado: (2019)

Renal arteries denervation: from the treatment of resistant hypertension to the treatment of atrial fibrillation
por: Versaci, Francesco, et al.
Publicado: (2021)

Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction
por: Markley, Roshanak, et al.
Publicado: (2023)

Simultaneous exercise stress cardiac magnetic resonance and cardiopulmonary exercise testing to elucidate the Fick components of aerobic exercise capacity: a feasibility and reproducibility study and pilot study in hematologic cancer survivors
por: Canada, Justin M., et al.
Publicado: (2023)

The Potential Role of Clinical Pharmacy Services in Patients with Cardiovascular Diseases
por: Talasaz, Azita Hajhossein
Publicado: (2012)

Successful use of the Impella Recover LP 5.0 device for circulatory support during off-pump coronary artery bypass grafting
por: Pepino, Paolo, et al.
Publicado: (2014)

Heart, Lung and Vessels... but brain and hands too! The case for a novel journal in the cardiovascular scholarly arena
por: Peruzzi, Mariangela, et al.
Publicado: (2015)

Individualised prognosis in out-of-hospital cardiac arrest: The case for P-ROSC in Asian people
por: Testa, Alberto, et al.
Publicado: (2022)

Air pollution and cardiovascular risk: is it time to change guidelines?
por: Bernardi, Marco, et al.
Publicado: (2022)

When early discharge after percutaneous coronary intervention is much too early
por: Siudak, Zbigniew, et al.
Publicado: (2022)

Out-of-hospital cardiac arrest: predict and then protect!
por: Spadafora, Luigi, et al.
Publicado: (2023)

Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus
por: Marawan, Amr, et al.
Publicado: (2021)

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
por: Dixon, Dave L, et al.
Publicado: (2017)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale
por: Samsonov, M., et al.
Publicado: (2021)

Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report
por: Giordano, Arturo, et al.
Publicado: (2016)

Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
por: Van Tassell, Benjamin W., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8ne0e26tfuos3ttd970950q0oh